All news

Survey reveals skyrocketing interest in cannabinoids for pain

Three-quarters (75%) of Americans who expressed interest in using cannabis or cannabinoids to address pain are under the impression they are safer or have fewer side effects than opioids or other medications, according to a nationwide survey commissioned by the American Society of Anesthesiologists

DEA Again Promises to Improve Access to Cannabis for Research

After years of stalling, the agency says it plans to provide notice on pending applications from growers—but only after it establishes new regulations for suppliers.

The UK's NICE Guidelines on Medical Cannabis Explained

The National Institute for Health and Care Excellence (NICE) recently released its draft guidelines for prescribing cannabis-based medical products (CBMPs) in the UK.

Is South Australia finally nearing its medicinal cannabis potential?

The ambitions of a large-scale medicinal cannabis industry in South Australia are about to be tested, with plans to create more than 1000 jobs at a major new manufacturing facility in Adelaide

Medicinal Cannabis: What does it take to be GMP ready?

The legalisation of cannabis for medicinal purposes pushes producers to supply chemists, physicians and patients with the newly approved drug in accordance with good manufacturing and distribution practices

High Hopes

Barry Lambert had no interest in medicinal cannabis until it saved his granddaughter from the ravages of a devastating illness.

Australia may have just accidentally imported illegal cannabis, does the government care?

Australian consumers could be exposed to illegal and potentially even harmful batches of cannabis as the scandal surrounding Canadian medicinal marijuana company CannTrust heads down under.

MGC to conduct medical cannabis driving trials

MGC’s product is a 20:1 cannabidiol to tetrahydrocannabinol compound formula that is authorised for prescription as an Investigational Medicinal Product in both Australia and the UK.

Transdermal CBD and Fragile X Syndrome

The aim of this study was to evaluate the safety, tolerability, and initial efficacy of a transdermal CBD gel in a pediatric population with Fragile X Syndrome

Medical cannabis for children slowly being recognized

When Alexander Repetski’s daughter Gwen was born seven years ago, she was “extraordinarily healthy.” But by the time she was 18 months old, doctors were telling Alex and his wife to buy a wheelchair accessible van.